ARCT - Arcturus Therapeutics GAAP EPS of -$0.61 beats by $1.04 revenue of $45.14M beats by $29.27M
2023-11-14 16:03:50 ET
More on Arcturus Therapeutics
- Arcturus: Interim Readout Of Rare Disease Data In Coming Months
- Arcturus: mRNA Therapies For Rare Diseases Accelerate Towards Proof Of Concept
- Arcturus Therapeutics Q3 2023 Earnings Preview
- Arcturus up 5% as cystic fibrosis candidate gets additional funding
- Seeking Alpha’s Quant Rating on Arcturus Therapeutics
For further details see:
Arcturus Therapeutics GAAP EPS of -$0.61 beats by $1.04, revenue of $45.14M beats by $29.27M